Braxia Scientific Corp (BRAX)

CSE
Currency in CAD
Disclaimer
0.03
0.00
(0.00%)
Closed
Unusual trading volume
Day's Range
0.02
0.03
52 wk Range
0.02
0.10
Volume
946,504
Prev. Close
0.03
Open
0.03
Day's Range
0.02-0.03
52 wk Range
0.02-0.1
Volume
946,504
Average Volume (3m)
332,343
1-Year Change
-50%
Shares Outstanding
263,708,939
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More

Braxia Scientific Corp News

Braxia Scientific Corp Analysis

Braxia Scientific Corp Company Profile

Braxia Scientific Corp. is a Canada-based medical research company. The Company is primarily focused on owning and operating multidisciplinary clinics, which provides treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. Its clinics provides ketamine and psilocybin treatments for depression and related disorders. It seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener, and Montreal. It offers Intravenous (IV) Ketamine, and Oral Ketamine Tablets. Its subsidiaries include Altmed Capital Corp., Tassili Life Science Corp., Artisan Growers Ltd., and Novo Formulations Ltd.